Restriction landmark genomic scanning (RLGS) is a method for visualizing restriction landmarks, employing direct labeling of restriction sites of genomic DNA and high-resolution two-dimensional electrophoresis. We determined the conditions for both the first and second dimensions of RLGS that define all of the restriction fragments which carry the Notl landmark. Using this system, we determined the number of cleavable Notl sites of genomic DNA from the mouse kidney (C57BL/6) and from the human placenta. The mouse and human genomes were cleaved at 2,380±80 sites (4,760±160 spots) and 3,240±110 sites (6,480±220 spots), respectively with Notl.
Restriction landmark genomic scanning (RLGS) is based upon the direct labeling of restriction landmark sites in genomic DNA. These end-labeled fragments are reduced in size by digestion v/ith a second endonuclease and the double-digest fragments are separated in the first dimension using agarose gel electrophoresis. 1 ' 2 The separated fragments are digested in-gel with a third restriction enzyme and the resulting fragments are separated in a polyacrylamide gel. The final distribution of end-labeled landmark fragments is analyzed by autoradiography. The total number of labeled spots and their distribution are determined by the enzyme combinations used and the electrophoretic conditions. However, it has been possible to identify routinely 1,500-2,000 landmark sites in mouse or human genomic DNA digested with combinations such as Notl, EaiRl, Mbol or Notl, Pvull, Pstl. In the standard conditions used for many analyses, there could be fragments separated in the first dimension that were not cleaved with the third enzyme. Under these conditions, the end-labeled fragments would not be separated in the size range of the second-dimensional gel. Similarly, there could be some fragments that were not separated in the first-dimensional gel in the size range that could detect electrophore:ic differences. As a con- An estimate of the total number of landmark sites that are present in the genome is an important issue in the use of RLGS for several genome analysis applications such as genetic mapping 3 and the identification of imprinted landmark sites that show parent allele-specinc methylation. 4 These determinations are critical for making a direct estimate of the proportion of these sites that have been examined either as genetic loci or as sites of genomic imprinting. Analysis of the number of CpG islands that may be associated with the promoter regions of functional genes indicates that there are approximately 3.7xlO 4 islands in the mouse and 4.5xlO 4 islands in the human genome. 5 The Notl recognition sequence is CpGrich and most likely is associated with CpG islands. 6 There are an estimated 3,000 Notl sites in the mammalian genome based upon the frequency of Notl sites in genomic DNA sequence databases.
We have used a modification of the RLGS method to estimate the number of Notl landmarks directly in mouse kidney genomic DNA and in the genomic DNA from human placenta. The first-and second-dimensional separation of genomic fragments was optimized using different gel concentrations and third enzyme combinations. Using this approach, all of the Notl sites were identified.
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H. Imoto et al. 241 We estimate that there were 2,380±80 Notl sites in the mouse genome (4,760 RLGS spots) and 3,240±110 Notl sites in human placental DNA ((5,480 RLGS spots). Figure 1 shows RLGS patterns, representing the entire mouse genome. The RLGS profile was sub-divided into five windows (I-V) to capture all of the Notl landmarks. The first and second dimensions (1-D, 2-D) of the five windows cover the following molecular sizes: I (2700-470 bp, origin-90 bp), II (origin-2500 bp, origin-90 bp), III (500-40 bp, 500-10 bp), IV (2700-470 bp, 210-10 bp) and V (origin-2500 bp, 210-10 bp).
RLGS Profiles in Five Windows
In windows I, II, IV and V, DNA fragments separated by the 1-D electrophoresis span from the origin to about 470 bp, with an average of several kilobase pairs, because the loaded sample was treated by Notl and BamHl. It is expectedly that there are no undetected spots located in the high-molecular region of 1-D since a 0.8% agarose gel electrophoretic separation in 1-D covers the range from origin to about 500 bp. A 5 or 10% polyacrylamide gel was used in the second dimension of these windows and the electrophoretic pattern of DNA markers showed that DNA fragments of 10 bp or less could be detected clearly without stacking (data not shown). The shortest fragments that are theoretically possible in the second dimension are 5'NTCGGGCC3' /3'AGCGCCGG5' (underline represents 32 P-labeled residues incorporated by filling reaction with Sequenase Ver 2.0), because Hinfl was used as restriction enzyme C. Thus, DNA fragments less than 8 bp is not produced. Therefore, we concluded that all of the DNA fragments which were located in the region of more than 500 bp in 1 he first dimension could be detected.
Window III was selected for the analysis of fragments in the first dimension of less than 500 bp, using a 1.5% agarose gel. A pilot experiment revealed that DNA fragments of less than 40 bp were separated in 60-cm long agarose disc gels (data not shown). CpG islands are preferentially cleaved when enzymes with GC-rich recognition sequences, such as Notl, are employed. Hinfl (5'GANTC3') was used to produce the RLGS patterns in Windows I, II, IV and V, avoiding the use of GC-rich 4-bp cutters such as Haelll and Hpall for the in-gel digestion step. These enzyme sites are also preferentially located close to Notl sites on CpG islands and their use would result in the production of short DNA pieces of labeled Notl fragments in the second dimension. On the other hand, Haelll and Hpall were used as restriction enzyme C in the analysis of Window III. The size of the DNA fragments separated in the first dimension of Window III were considerably shorter than the fragment sizes separated in the other windows, spanning 500-40 bp. Therefore, the cleavage by in-gel digestion with the enzyme recognizing 4-bp sequences including A and T was expected to be very infrequent in the DNA fragments located in Window III, resulting in insufficient separation of these fragments with almost all spots remaining on the diagonal parabola line. Furthermore, Haelll is sensitive to methylation at the 5-position of the first cytosine residue of GGCC but not at the second cytosine residue. Almost all of the methylation in the mammalian genome occurs at the CpG dinucleotide. 7 Thus, Haelll is the most suitable enzyme for separation of spots in Window III and is least affected by methylation.
It was difficult to superimpose the patterns of the adjacent Windows I and IV with Window III as we used different enzymes for the in-gel digestion. To identify the border of these regions, we adopted genomic DNAs mixed with a 489-bp marker DNA which shows enhanced spots in these windows. In Fig. 1 , these enhanced spots are indicated by arrowheads. Thus, we could avoid redundant counting of the same spots. Figure 1 . RLGS profiles of 5 regions covering all Notl sites in whole mouse genome, (a) Schematic representation for dividing whole the RLGS profile into 5 RLGS windows to cover the whole range. To cover all RLGS spots derived from the whole genome, the RLGS region was divided into five windows (Window I, II, III, IV and V). Windows I through V for the first dimension cover 2,700-470 bp, origin-2,500 bp, 500-40 bp, 2700-470 bp and origin-2,500 bp, respectively. Each window overlaps with its neighbors enabling boundaries between windows to be identified. For the second dimensions, Windows I through V cover origin-90 bp, origin-90 bp, 500-10 bp, 210-10 bp and 210-10 bp, respectively. The size markers for the first and second dimension are indicated on the vertical and horizontal edges of Fig. l(a) and l(b) . ori., origin (b) RLGS profiles of 5 windows covering all Notl sites in the mouse genome. We used the inbred mouse C57BL/6 kidney and human placenta. The method for preparation of high-molecular-weight DNA and RLGS protocol was described elsewhere 2 . Notl and BamHl were used as restriction enzyme A and B, respectively. Hinfl, Haelll and Hapll were used as restriction enzyme C depending on the window. The appropriate conditions for these five windows were as follows. The 1-D electrophoreses to produce Window I, II, IV and V were performed in a 0.8% agarose gel at 4.5 V/cm for 24 h, and for Window III, we used 1.5% agarose gel electrophoresis at 13 V/cm for 8 h. For 2-D electrophoreses of Windows I and II, we used 5% polyacrylamide gel electrophoresis at 4 V/cm for 20 h and those for Windows III, IV and V were performed on a 10% polyacrylamide gel, which had been pre-run sufficiently to prevent stacking at 7.5 V/cm for 14 h. Since restriction enzyme C for Window III was different from those of others, these two RLGS patterns can not be superimposed on each other. To avoid redundant spot counting, the boundary between these two windows was identified by the marker spots indicated by the arrowheads which were enhanced spots produced by mixing 489-bp marker DNA clone. The boundary of other ranges could be identified by superimposing the RLGS pattern. The number of landmarks in each window were counted regardless of the intensities of the spots. 
Total Number of Noil Sites in Human and Mouse Genome
The whole-range RLGS reported in this paper enables us to detect nearly all the Notl landmarks in the RLGS spots. Notl cleaved the mouse and human genomes at 2,380±80 and 3,240±110 sites, respectively. There are about 50 Notl sites on the 50-Mbp-long human chromosome 21, 8 although this figure was based on cell line data, whose level of DNA methylation might differ from that of non-cultured tissues [5-10% of CpG sites; (ref 9 and our unpublished data)]. These results provide an estimate of 3,000 Notl sites for the entire human genome which is in agreement with our results. The number of Notl sites in the mouse genome is 72% as many as that in the human genome, reflecting the expectation reported by Antequela et al. that about 20% of human CpG islands are absent from the homologous mouse genes. 
Direct Enumeration of Notl Sites in Mouse and Human Genomes by Whole-range RLGS
Our data indicated that almost all Notl sites throughout the genome were detected in five windows which were designed to cover all ranges in 1-D and 2-D and that the mouse and human genomes were cleaved at 2,380±80 and 3,240±110 sites with Notl. Conventional data for the number of "Not! sites were compiled from sequence databases, such as GENBANK and EMBL. However, such sequence data do not reflect tissue-specific differences in methylation, which might affect cleavage by restriction enzymes. Whole-range RLGS enables the direct detection of those restriction sites which can be digested in a particular tissue.
Population of CpG Islands with Notl Sites
Our data demonstrated that the total numbers of Notl sites were 2,380±80 and 3,240±110 per haploid genome in the mouse and human genomes, respectively. It has been reported that 89% of all Notl sites are located in CpG islands. 6 Therefore, it is calculated that the numbers of Notl sites located in CpG islands are about 2,140 and 2,850. On the other hand, Antequera et al. reported that the number of CpG islands could be calculated to be 37,000 and 45,000, respectively, from the data of the ratio of radioactivity incorporated into Hapll tiny DNA fragments compared with those of total DNA. 5 These data lead us to estimate that 5.7% and 6.4% of all CpG islands carry Notl sites that are unmethylated and cleaved in mouse kidney and human placenta.
Applications of the Direct Detection of Total
Enzyme Cleavage Sites RLGS methods have been used for genetic mapping 3 and for detecting alterations in cancer. 10 The methylation-sensitive properties of Notl have also been used to identify loci that change during differentiation of neuroepithelial cells 9 and to identify allelic differences that show imprinted patterns of transmission. 4 Notl landmark enzyme cleavage was used in each of these studies and it is critical to know the relative abundance of Notl sites when planning additional studies in each of these areas. For example, more than 1,000 loci have been identified and mapped in various mouse crosses. It is increasingly likely that the proportion of independent loci will diminish significantly in the analyses of additional enzyme combinations or different parental crosses. Similarly, the analysis of additional crosses and enzyme combinations for imprinted Notl sites may yield only a modest increase in the estimated number of imprinted loci since the total number of predicted imprinted genes is around 100.
Finally, the direct estimate of the number of Notl cleavage sites is important for establishing Notl linking libraries of either the mouse or human genome. We have previously used the Notl restriction trapper method to isolate genomic Notl sites for the construction ^oil-linking and boundary libraries. 12 The estimates from this study will guide the formation of arrayed ^oil-linking libraries that can be used for the co-localization of Notllinking clones with specific RLGS spots by an ordered mixing of clones with genomic DNA that is subsequently subjected to RLGS analyses.
Thus, whole-range RLGS provides us a very powerful tool to analyze the accessible restriction sites throughout the whole genome.
